SCHEMBL12507358

SCHEMBL12507358

COc1cccc(NC(=O)CNc2nnc(-c3ccc4[nH]nc(C)c4c3)o2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 6/20 0.49
▸ SMN1; SMN2 Q16637 4/20 0.49
▸ TP53 P04637 3/20 0.49
▸ PKM P14618 1/20 0.49
▸ RAB9A P51151 1/20 0.49
▸ FLT3 P36888 1/20 0.47
▸ ADCY1 Q08828 1/20 0.45
▸ MAPT P10636 2/20 0.45
▸ HAVCR2 Q8TDQ0 1/20 0.45
▸ CA12 O43570 1/20 0.44
▸ CA1 P00915 1/20 0.44
▸ CA2 P00918 1/20 0.44
▸ CA9 Q16790 1/20 0.44
▸ TSHR P16473 2/20 0.44
▸ ALOX15 P16050 1/20 0.44
▸ HSD17B10 Q99714 1/20 0.44
▸ CDC7 O00311 1/20 0.44
▸ CCNE1 P24864 1/20 0.44
▸ CDK2 P24941 1/20 0.44
▸ DBF4 Q9UBU7 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2190075 0.92 CDC7 (0.55) KDM4ESMN1; SMN2TP53PKMRAB9A
SCHEMBL12507229 0.89 TP53 (0.47) KDM4ESMN1; SMN2TP53PKMRAB9A
SCHEMBL2191201 0.84 RAB9A (0.55) KDM4ESMN1; SMN2TP53PKMRAB9A
SCHEMBL13463231 0.79 KDM4E (0.52) KDM4ESMN1; SMN2TP53PKMRAB9A
SCHEMBL2189787 0.78 KDM4E (0.51) KDM4ESMN1; SMN2TP53PKMRAB9A
SCHEMBL12506950 0.73 CDC7 (0.74) KDM4ESMN1; SMN2CDC7CCNE1CDK2
SCHEMBL2190317 0.72 CDC7 (0.58) KDM4ESMN1; SMN2FLT3MAPTCDC7
SCHEMBL12907599 0.67 CHEK1 (0.59) KDM4ESMN1; SMN2TP53RAB9AMAPT
SCHEMBL2188384 0.66 CDK2 (0.52) KDM4ESMN1; SMN2ADCY1MAPTCDC7
SCHEMBL25195476 0.66 TLR8 (0.46) CDC7CCNE1CDK2DBF4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2102197-B1 5-([1,3,4]OXADIAZOL-2-YL)-1H-INDAZOL AND 5-([1,3,4]THIADIAZOL-2-YL)-1H-INDAZOL DERIVATIVES AS SGK INHIBITORS FOR THE TREATMENT OF DIABETES MERCK PATENT GMBH (DE) 2011-07-13 — — EP disclosed
Send feedback